Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Thompson Peter A
Relationship:   Director
City:   Bellevue
State:   WA
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   385,419    

Indirect Shares

   41,741,947      
Direct Value   $0    

Indirect Value

   $297,817,324      
Total Shares   42,127,366      
Total Value   $297,817,324      


Trubion Pharmaceuticals, Inc $0 Trubion Pharmaceuticals, Inc $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    4    

     Stock price went up :
    1   
    2    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   19.0%
 337.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Trubion Pharmaceuticals, Inc TRBN President and CEO, Dir... 2009-05-22 385,419 2009-05-22 1,000    Premium*  
            Sierra Oncology Inc SRRA Director 2015-07-21 0 2015-07-21 1,989,949    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director 0 2018-06-06 4,901,310    Premium*  
            Corvus Pharmaceuticals, Inc. CRVS Director, 10% Owner 2016-03-29 0 2021-09-20 6,943,654    Premium*  
            Alpine Immune Sciences Inc ALPN Director 2017-07-24 0 2024-01-11 2,680,496    Premium*  
            Synthorx, Inc. THOR Director, 10% Owner 2018-12-11 0 2020-01-23 0    Premium*  
            Prevail Therapeutics Inc. PRVL Director, 10% Owner 0 2021-01-22 0    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP Director, 10% Owner 2020-09-29 0 2020-09-29 114,039    Premium*  
            Silverback Therapeutics, Inc. SBTX Director 0 2023-08-29 9,240,887    Premium*  
            Decibel Therapeutics, Inc. DBTX Director, 10% Owner 2021-02-17 0 2021-02-17 883,418    Premium*  
            Edgewise Therapeutics, Inc. EWTX Director, 10% Owner 0 2024-01-23 14,756,096    Premium*  
            Janux Therapeutics, Inc. JANX Director 2021-12-16 0 2021-12-29 231,098    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
EWTX Edgewise Therapeutics, In... Director   –       •       •   2024-01-23 4 B $11.00 $4,999,995 I/I 454,545 14,436,497 2.25 -
ALPN Alpine Immune Sciences In... Director   –       •      –    2024-01-11 4 OE $12.74 $1,850,498 I/I 145,251 2,416,181 0 -
ALPN Alpine Immune Sciences In... Director   –       •      –    2023-12-28 4 S $18.32 $25,049,034 I/I (1,364,849) 264,315 0 %
ALPN Alpine Immune Sciences In... Director   –       •      –    2023-12-27 4 S $19.96 $3,622,700 I/I (181,498) 406,609 0 %
SBTX Silverback Therapeutics, ... Director   –       •      –    2023-08-29 4 B $6.20 $3,100,000 I/I 500,000 8,019,187 2.1 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2022-09-16 4 B $10.32 $4,999,999 I/I 484,496 13,981,952 2.25 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2022-05-18 4 B $7.21 $994,980 I/I 138,000 13,497,456 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-29 4 S $20.30 $820,120 I/I (40,400) 231,098 0 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-21 4 S $19.00 $2,268,600 I/I (119,400) 234,798 0 -
JANX Janux Therapeutics, Inc. Director   –       •      –    2021-12-16 4 S $19.07 $7,500,231 I/I (393,300) 245,898 0 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2021-09-20 4 S $6.09 $6,757,732 I/I (1,109,644) 6,943,654 0 %
ALPN Alpine Immune Sciences In... Director   –       •       •   2021-09-17 4 B $9.40 $9,499,988 I/I 1,010,637 425,531 2.25 %
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-30 4 B $16.00 $5,750,000 I/I 359,375 13,359,456 2.25 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-30 4 A $0.00 $0 I/I 13,002,760 272,724 0 -
EWTX Edgewise Therapeutics, In... Director   –       •       •   2021-03-25 3 IO $0.00 $0 I/I 0 316,920 -
CRVS Corvus Pharmaceuticals, I... Director   –       •       •   2021-02-17 4 B $3.50 $4,499,999 I/I 1,285,714 8,053,298 2.25 %
DBTX Decibel Therapeutics, Inc... Director   –       •       •   2021-02-17 4 B $18.00 $29,999,988 I/I 1,666,666 883,418 2.25 -
DBTX Decibel Therapeutics, Inc... Director   –       •       •   2021-02-17 4 A $0.00 $0 I/I 3,278,526 218,568 0 -
PRVL Prevail Therapeutics Inc. Director   –       •       •   2021-01-22 4 D $0.00 $0 I/I (13,822,463) 0 0 -
ALPN Alpine Immune Sciences In... Director   –       •       •   2020-12-28 4 S $14.25 $8,550,000 I/I (600,000) 3,070,955 0 %
SBTX Silverback Therapeutics, ... Director   –       •       •   2020-12-08 4 B $21.00 $25,000,017 I/I 1,190,477 952,377 2.25 -
SBTX Silverback Therapeutics, ... Director   –       •       •   2020-12-08 4 A $0.00 $0 I/I 7,011,765 7,519,188 0 -
SBTX Silverback Therapeutics, ... Director   –       •       •   2020-12-03 3 IO $0.00 $0 I/I 0 538,646 -
PMVP Pmv Pharmaceuticals, Inc. Director   –       •       •   2020-09-29 4 A $0.00 $0 I/I 6,114,330 114,039 0 -
PMVP Pmv Pharmaceuticals, Inc. Director   –       •       •   2020-09-25 4 B $18.00 $17,100,000 I/I 950,000 475,000 2.25 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us